Effect of Trimethoprim-Sulfamethoxazole Prophylaxis on Antimicrobial Resistance of Fecal Escherichia coli in HIV-Infected Patients in Tanzania

BACKGROUND: Trimethoprim-sulfamethoxazole (SXT) reduces morbidity and mortality among HIV-infected persons in Africa, but its impact on antimicrobial resistance is of concern. METHODS: HIV-uninfected (group A), HIV-infected but not requiring SXT (group B), and HIV-infected and eligible for SXT (grou...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Morpeth, Susan C., Thielman, Nathan M., Ramadhani, Habib O., Hamilton, John D., Ostermann, Jan, Kisenge, Peter R., Shao, Humphrey J., Reller, L. Barth, Itemba, Dafrosa K., Sam, Noel E., Bartlett, John A., Shao, John F., Crump, John A.
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2586846/
https://ncbi.nlm.nih.gov/pubmed/18285712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e31816856db
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars